If you are:
Only When Necessary: NEONATAL WITHDRAWAL/RESP.DEPRESS. W/CHRONIC OR HIGH DOSE; SMALL TERATOGENIC RISK
Precaution: LIMITED DATA REPORT ADVERSE EFFECTS; MONITOR FOR DYSPNEA,FEEDING DIFFICULTIES
An adult over 60:
management or monitoring precaution: Pulmonary-Life threatening respiratory depression is more likely to occur with high doses, SR products, cachexia, or debilitation due to altered pharmacokinetics with poor fat stores, muscle wasting, or altered clearance. Monitor closely at initiation and with dose titration. Neuro/Psych-Risk for increased confusion and delirium. May increase fall risk. Avoid treatment with 3 or more CNS active drugs. Gastrointestinal-Constipation risk. Urogenital-Urinary retention risk.
Giving Hydromorphone HCL-0.9% NaCl Patient Controlled Analgesia Syringe to a child under 12:
Severe Precaution: Potential increased sensitivity to effects, adverse CNS effects and respiratory depression.